Imunon
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Imunon generated cash of -$19,022,148, which is more than the previous year. Cash used in financing activities reached the amount of -$3,638,562 last year. Net change in cash is therefore -$11,654,275.
Cash Flow
| 2014 | -21.35M | 9.54M | 18.77M |
|---|---|---|---|
| 2015 | -20.83M | 13.32M | 4.08M |
| 2016 | -18.37M | 9.06M | 2.67M |
| 2017 | -16.64M | -10.99M | 36.45M |
| 2018 | -7.04M | -1.63M | 10.58M |
| 2019 | -20.25M | 5.93M | 7.84M |
| 2020 | -15.61M | 7.92M | 17.98M |
| 2021 | -16.22M | -30.12M | 54.76M |
| 2022 | -23.13M | 8.31M | 6.72M |
| 2023 | -19.02M | 11.00M | -3.63M |
CLSN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.49M | 25.58M | 17.16M | 6.87M | 13.35M | 11.44M | 2.62M | 9.26M | 12.68M | 5.71M |
Operating activities | ||||||||||
Net income | -19.51M | -35.89M | -20.76M | -21.48M | -16.85M | -11.88M | -20.40M | -22.05M | -22.46M | -25.49M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 720.00K | 731.62K | 702.91K | 741.52K | 721.66K | 356.85K | 553.01K | 1.02M | 424.96K | 369.32K |
Stock-based compensation expense | 800K | 2.7M | 3.75M | 1.85M | 2.3M | 0 | 1.10M | 1.51M | 1.84M | 2.58M |
| Deferred income tax benefit | 800K | 2.7M | 3.75M | 1.85M | 2.3M | 0 | 1.10M | 1.51M | 1.84M | 2.58M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 68.13K | 0 | 0 | 0 | 46.94K | 0 | -50.43K | 0 | 183.30K | 0 |
Inventories | 0 | 0 | 0 | 0 | -46.94K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.99M | 1.03M | 302.40K | -618.10K | -157.68K | -396.22K | 537.88K | 48.75K | -859.18K | 1.76M |
Cash generated by operating activities | -19.02M | -23.13M | -16.22M | -15.61M | -20.25M | -7.04M | -16.64M | -18.37M | -20.83M | -21.35M |
Investing activities | ||||||||||
Purchases Of Investments | -13.54M | -48.19M | -53.81M | -9.95M | -23.82M | -16.97M | -12.73M | -4.51M | -21.07M | -29.82M |
Investments In Property Plant And Equipment | -451.75K | -267.8K | -311.61K | -19.09K | -349.15K | -138.39K | -38.62K | -62.50K | -109.34K | -672.25K |
Acquisitions Net | 0 | -8.58M | 29.81M | -7.94M | -6.28M | 0 | 0 | 0 | 0 | -2.82M |
Cash generated by investing activities | 11.00M | 8.31M | -30.12M | 7.92M | 5.93M | -1.63M | -10.99M | 9.06M | 13.32M | 9.54M |
Financing activities | ||||||||||
Common Stock Issued | 2.78M | 6.72M | 52.68M | 22.81M | 7.84M | 858.51K | 17.91M | 6.77M | 7.73M | 13.78M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -5.19M | -6.52M | 0 | 0 | -2.59M | -4.09M | -3.65M | -10.89K |
Cash used in financing activities | -3.63M | 6.72M | 54.76M | 17.98M | 7.84M | 10.58M | 36.45M | 2.67M | 4.08M | 18.77M |
Net Change In Cash | -11.65M | -8.09M | 8.42M | 10.28M | -6.47M | 1.90M | 8.81M | -6.64M | -3.42M | 6.96M |
Cash at end of period | 5.83M | 17.49M | 25.58M | 17.16M | 6.87M | 13.35M | 11.44M | 2.62M | 9.26M | 12.68M |
| Data source | Data source |